TY - JOUR
AU - M. Barclay
AU - C. Renzi
AU - A. Antoniou
AU - S. Denaxas
AU - H. Harrison
AU - S. Ip
AU - N. Pashayan
AU - A. Torralbo
AU - J. Usher-Smith
AU - A. Wood
AU - G. Lyratzopoulos
AD - Department of Behavioural Science and Health, Institute of Epidemiology and Healthcare, University College London, London, United Kingdom.
Faculty of Medicine, University Vita-Salute San Raffaele, Milan, Italy.
Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom.
Institute of Health Informatics, University College London, London, United Kingdom.
Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, United Kingdom.
Department of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, London, United Kingdom.
British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, United Kingdom.
National Institute for Health and Care Research Blood and Transplant Research Unit in Donor Health and Behaviour, University of Cambridge, Cambridge, United Kingdom.
Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, United Kingdom.
Cambridge Centre for Artificial Intelligence in Medicine, University of Cambridge, Cambridge, United Kingdom.
AN - 38100737
BT - PLOS Digit Health
C2 - PMC10723831 Monitoring Committee, outside the submitted work. No other disclosures were reported.
DO - 10.1371/journal.pdig.0000383
DP - NLM
ET - 2023/12/15
LA - eng
M1 - 12
N1 - 2767-3170
Barclay, Matthew
Orcid: 0000-0003-1148-1922
Renzi, Cristina
Antoniou, Antonis
Denaxas, Spiros
Harrison, Hannah
Ip, Samantha
Pashayan, Nora
Torralbo, Ana
Usher-Smith, Juliet
Orcid: 0000-0002-8501-2531
Wood, Angela
Lyratzopoulos, Georgios
Journal Article
United States
PLOS Digit Health. 2023 Dec 15;2(12):e0000383. doi: 10.1371/journal.pdig.0000383. eCollection 2023 Dec.
PY - 2023
SN - 2767-3170
EP - e0000383
T2 - PLOS Digit Health
TI - Phenotypes and rates of cancer-relevant symptoms and tests in the year before cancer diagnosis in UK Biobank and CPRD Gold
VL - 2
ER -